![G. Wesley Hatfield](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
G. Wesley Hatfield active positions
Companies | Position | Start | End |
---|---|---|---|
Actavalon, Inc.
![]() Actavalon, Inc. Pharmaceuticals: MajorHealth Technology Actavalon, Inc. operates as a preclinical stage pharmaceutical company. It focuses on the development of a single, broad spectrum, drug with the potential to target and eradicate human cancer cells of all types such as breast, lung, pancreatic and colon cancer among others. The company was founded by Ned Israelsen and Wesley G. Hatfield and is headquartered in San Diego, CA. | Director/Board Member | - | - |
Founder | - | - | |
Chief Executive Officer | - | - |
Career history of G. Wesley Hatfield
Former positions of G. Wesley Hatfield
Companies | Position | Start | End |
---|---|---|---|
Verdezyne, Inc.
![]() Verdezyne, Inc. Pharmaceuticals: OtherHealth Technology Verdezyne, Inc. operates as an industrial biotechnology company. It designs and engineers enzymes, metabolic pathways, and microorganisms that produce target chemicals. The firm offers Biolon DDDA, Adipic acid, and Sebacic Acid. The company was founded in 2005 and is headquartered in Carlsbad, CA. | Founder | 2004-12-31 | - |
Statistics
International
United States | 3 |
Operational
Founder | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Verdezyne, Inc.
![]() Verdezyne, Inc. Pharmaceuticals: OtherHealth Technology Verdezyne, Inc. operates as an industrial biotechnology company. It designs and engineers enzymes, metabolic pathways, and microorganisms that produce target chemicals. The firm offers Biolon DDDA, Adipic acid, and Sebacic Acid. The company was founded in 2005 and is headquartered in Carlsbad, CA. | Health Technology |
Actavalon, Inc.
![]() Actavalon, Inc. Pharmaceuticals: MajorHealth Technology Actavalon, Inc. operates as a preclinical stage pharmaceutical company. It focuses on the development of a single, broad spectrum, drug with the potential to target and eradicate human cancer cells of all types such as breast, lung, pancreatic and colon cancer among others. The company was founded by Ned Israelsen and Wesley G. Hatfield and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- G. Wesley Hatfield
- Experience